Study wrapper · #875
Treatment Patterns and Experienced Effects of Semaglutide for Weight Management Among Adult Users in Denmark: A Community Pharmacy-Based Cross-Sectional Survey.
Editor's note
A cross-sectional pharmacy survey documenting real-world semaglutide dosing patterns and self-reported outcomes for weight management. Weight-loss figures are self-reported and the design is observational, so they describe association and user experience rather than controlled efficacy. The finding that many stay at 1 mg with comparable reported results is a useful, if hypothesis-generating, signal on individualized dosing.
Plain-language abstract
In a Danish pharmacy survey of 767 semaglutide weight-management users, self-reported weight loss rose with longer treatment duration, and many users stayed on the 1 mg dose while reporting effects similar to higher-dose users. About a quarter reported reducing or stopping other medications after starting.